Active Ingredient: Bicalutamide 50mg.
Manufacturer: Cipla.
Primary Indication: Treatment of Stage D2 metastatic carcinoma of the prostate in combination with LHRH analogs (e.g., leuprolide, goserelin).
Mechanism of Action: A non-steroidal anti-androgen that binds to androgen receptors, preventing testosterone from promoting cancer cell growth.
Dosage Form: Oral film-coated tablet.
Dosage: Typically prescribed as 50mg daily.
Bicalutamide Tablets 50 Mg (Calutide) Supplier & Exporter | Fulvestrant Injection India, USA, Washington .
Buy Bicalutamide Tablets 50 Mg (Calutide) from trusted exporter City Drug Exporters. High-quality oncology medicine with global shipping and cold-chain delivery.
City Drug Exporters is a trusted global supplier offering this oncology product with strict quality standards and cold-chain logistics.
